PRIME MEDICINE INC (PRME) Stock Analyst Ratings
NASDAQ:PRME - Nasdaq - US74168J1016 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 84% to PRME. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 14.17. This target is 753.41% above the current price.
PRME was analyzed by 18 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about PRME.
In the previous month the buy percentage consensus was at a similar level.
PRME was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-03-20 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-03-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-04 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2025-03-03 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-03-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-10 | JMP Securities | Initiate | Market Outperform |
| 2024-12-03 | Guggenheim | Reiterate | Buy -> Buy |
| 2024-11-13 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-11-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-20 | HC Wainwright & Co. | Initiate | Buy |
| 2024-05-16 | Citigroup | Upgrade | Neutral -> Buy |
| 2024-05-13 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-04-23 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-04-22 | Chardan Capital | Initiate | Buy |
| 2024-04-08 | TD Cowen | Initiate | Buy |
| 2024-04-03 | Wedbush | Initiate | Outperform |
| 2024-04-02 | Wedbush | Initiate | Outperform |
| 2024-03-05 | Guggenheim | Maintains | Buy -> Buy |
| 2023-12-08 | Citigroup | Initiate | Neutral |
| 2023-11-07 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-10-09 | BMO Capital | Initiate | Outperform |
| 2023-09-06 | JonesTrading | Initiate | Buy |
| 2023-08-14 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-07-31 | Guggenheim | Initiate | Buy |
| 2023-04-18 | Stifel | Initiate | Buy |
| 2023-01-24 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-11-14 | JP Morgan | Initiate | Overweight |